HomeClinical TopicsFDA approves new drugs

FDA approves new drugs

  • ·On Sept. 22, the U.S. Food and Drug Administration (FDA) approved Lonsurf (a pill that combines two drugs, trifluridine and tipiracil) for patients with advanced colorectal cancer who are no longer responding to other therapies. Read more
  • On Sept. 17, the FDA approved Vraylar (cariprazine) capsules to treat schizophrenia and bipolar disorder in adults. Read more

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

NP taking pregnant woman's blood pressure

AHA: It’s Safe to Treat High Blood Pressure During Pregnancy

High blood pressure during pregnancy can present significant risks to mother and child, but practitioners have sometimes be hesitant to prescribe blood pressure medication...